A M Boesen - JoVE Visualize

Showing results (21-30 of 28) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 28 results.

Danish Medical Bulletin|June 10, 2006

Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publicationH Schrøder, M Kjeldahl, A M Boesen, et al.

Leukemia & Lymphoma|December 1, 1993

Incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin's lymphomas. Population-based data from a Danish lymphoma registryF D'Amore, B E Christensen, K Thorling, et al.

Leukemia & Lymphoma|October 1, 1995

Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer RegistryM Krogh-Jensen, F D'Amore, M K Jensen, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994

Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFOM Krogh-Jensen, F d'Amore, M K Jensen, et al.

Ugeskrift for Laeger|July 29, 1996

[Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse]M K Jensen, F A d'Amore, M K Jensen, et al.

Leukemia|June 1, 1991

Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, DenmarkO P Hansen, J Pedersen-Bjergaard, J Ellegaard, et al.

Leukemia|January 1, 1997

Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AMLP de Nully Brown, T Hoffmann, O P Hansen, et al.

Leukemia & Lymphoma|December 1, 1996

Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell supportH E Johnsen, B Björkstrand, K Carlson, et al.

Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 28 results.

Danish Medical Bulletin|June 10, 2006

Acute lymphoblastic leukemia in adolescents between 10 and 19 years of age in Denmark--secondary publicationH Schrøder, M Kjeldahl, A M Boesen, et al.

Leukemia & Lymphoma|December 1, 1993

Incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin's lymphomas. Population-based data from a Danish lymphoma registryF D'Amore, B E Christensen, K Thorling, et al.

Leukemia & Lymphoma|October 1, 1995

Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer RegistryM Krogh-Jensen, F D'Amore, M K Jensen, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994

Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFOM Krogh-Jensen, F d'Amore, M K Jensen, et al.

Ugeskrift for Laeger|July 29, 1996

[Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse]M K Jensen, F A d'Amore, M K Jensen, et al.

Leukemia|June 1, 1991

Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, DenmarkO P Hansen, J Pedersen-Bjergaard, J Ellegaard, et al.

Leukemia|January 1, 1997

Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AMLP de Nully Brown, T Hoffmann, O P Hansen, et al.

Leukemia & Lymphoma|December 1, 1996

Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell supportH E Johnsen, B Björkstrand, K Carlson, et al.

Pageof 3